A comprehensive map of the mTOR signaling network

被引:172
作者
Caron, Etienne [1 ,2 ]
Ghosh, Samik [3 ]
Matsuoka, Yukiko [3 ,4 ]
Ashton-Beaucage, Dariel [1 ]
Therrien, Marc [1 ,5 ]
Lemieux, Sebastien [1 ,9 ]
Perreault, Claude [1 ,2 ]
Roux, Philippe P. [1 ,5 ]
Kitano, Hiroaki [3 ,6 ,7 ,8 ]
机构
[1] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada
[3] Syst Biol Inst, Minato Ku, Tokyo 1080071, Japan
[4] JST ERATO KAWAOKA Infect Induced Host Responses P, Tokyo, Japan
[5] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada
[6] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan
[7] Japanese Fdn Canc Res, Inst Canc, Div Syst Biol, Tokyo 170, Japan
[8] Okinawa Inst Sci & Technol, Open Biol Unit, Okinawa, Japan
[9] Univ Montreal, Fac Arts & Sci, Dept Comp Sci & Operat Res, Montreal, PQ H3C 3J7, Canada
基金
日本学术振兴会; 加拿大健康研究院;
关键词
cancer; CellDesigner; graphical notation; mTOR; regulatory network; RIBOSOMAL S6 KINASE; TUMOR-SUPPRESSOR COMPLEX; RICH AKT SUBSTRATE; 40 KDA PRAS40; MAMMALIAN TARGET; CELL-GROWTH; TUBEROUS SCLEROSIS; TSC1-TSC2; COMPLEX; CANCER-THERAPY; RAPAMYCIN MTOR;
D O I
10.1038/msb.2010.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian target of rapamycin (mTOR) is a central regulator of cell growth and proliferation. mTOR signaling is frequently dysregulated in oncogenic cells, and thus an attractive target for anticancer therapy. Using CellDesigner, a modeling support software for graphical notation, we present herein a comprehensive map of the mTOR signaling network, which includes 964 species connected by 777 reactions. The map complies with both the systems biology markup language (SBML) and graphical notation (SBGN) for computational analysis and graphical representation, respectively. As captured in the mTOR map, we review and discuss our current understanding of the mTOR signaling network and highlight the impact of mTOR feedback and crosstalk regulations on drug-based cancer therapy. This map is available on the Payao platform, a Web 2.0 based community-wide interactive process for creating more accurate and information-rich databases. Thus, this comprehensive map of the mTOR network will serve as a tool to facilitate systems-level study of up-to-date mTOR network components and signaling events toward the discovery of novel regulatory processes and therapeutic strategies for cancer. Molecular Systems Biology 6: 453; published online 21 December 2010; doi:10.1038/msb.2010.108
引用
收藏
页数:14
相关论文
共 119 条
[111]   mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action [J].
Soliman, Ghada A. ;
Acosta-Jaquez, Hugo A. ;
Dunlop, Elaine A. ;
Ekim, Bilgen ;
Maj, Nicole E. ;
Tee, Andrew R. ;
Fingar, Diane C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) :7866-7879
[112]   An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1 [J].
Thoreen, Carson C. ;
Kang, Seong A. ;
Chang, Jae Won ;
Liu, Qingsong ;
Zhang, Jianming ;
Gao, Yi ;
Reichling, Laurie J. ;
Sim, Taebo ;
Sabatini, David M. ;
Gray, Nathanael S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (12) :8023-8032
[113]   Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 [J].
Vander Haar, Emilie ;
Lee, Seong-il ;
Bandhakavi, Sricharan ;
Griffin, Timothy J. ;
Kim, Do-Hyung .
NATURE CELL BIOLOGY, 2007, 9 (03) :316-U126
[114]   RAPAMYCIN (AY-22,989), A NEW ANTIFUNGAL ANTIBIOTIC .1. TAXONOMY OF PRODUCING STREPTOMYCETE AND ISOLATION OF ACTIVE PRINCIPLE [J].
VEZINA, C ;
KUDELSKI, A ;
SEHGAL, SN .
JOURNAL OF ANTIBIOTICS, 1975, 28 (10) :721-726
[115]   Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation [J].
Wang, Lifu ;
Harris, Thurl E. ;
Lawrence, John C., Jr. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (23) :15619-15627
[116]   Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR [J].
Wang, Lifu ;
Lawrence, John C., Jr. ;
Sturgill, Thomas W. ;
Harris, Thurl E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (22) :14693-14697
[117]  
Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
[118]   Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition [J].
Yip, Calvin K. ;
Murata, Kazuyoshi ;
Walz, Thomas ;
Sabatini, David M. ;
Kang, Seong A. .
MOLECULAR CELL, 2010, 38 (05) :768-774
[119]   Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin [J].
Yu, Ker ;
Toral-Barza, Lourdes ;
Shi, Celine ;
Zhang, Wei-Guo ;
Lucas, Judy ;
Shor, Boris ;
Kim, Jamie ;
Verheijen, Jeroen ;
Curran, Kevin ;
Malwitz, David J. ;
Cole, Derek C. ;
Ellingboe, John ;
Ayral-Kaloustian, Semiramis ;
Mansour, Tarek S. ;
Gibbons, James J. ;
Abraham, Robert T. ;
Nowak, Pawel ;
Zask, Arie .
CANCER RESEARCH, 2009, 69 (15) :6232-6240